Dorothy A Shoup, MD
Obstetrics/Gynecology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 4 carriers
- Office
- 1
Offices
1 location · Lpch Medical Group Div of Lucile · 332 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
13 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shoup’s office at (650) 498-7200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G64767 · Current
Licensed to practise in California · since 1988 · expires 2028-01-31 · Case Western Reserve University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$5,133
Medicare paid this office $5,133 for 44 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 15 | $1,195 | $75 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 21 | $1,191 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 21 | $994 | $47 |
Who their Medicare patients are
44 Original Medicare patients in 2024. Average age 76 · Women 100% · Health risk score 0.68. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 61%.
The office billed $21,018, Medicare allowed $6,379 and paid $5,133; for 79 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 44 | 79 | 76 | 0.68 | $21,018 | $5,133 |
| 2023 | 38 | 65 | 75 | 0.63 | $14,441 | $4,031 |
| 2022 | 52 | 87 | 75 | 0.64 | $21,511 | $5,499 |
| 2021 | 53 | 105 | 74 | 0.81 | $37,256 | $8,575 |
| 2020 | 43 | 80 | 74 | 0.75 | $15,608 | $4,309 |
| 2019 | 62 | 111 | 75 | 0.69 | $32,372 | $6,883 |
| 2018 | 48 | 92 | 73 | 0.65 | $28,860 | $5,740 |
| 2017 | 59 | 113 | 73 | 0.73 | $22,534 | $6,540 |
| 2016 | 173 | 233 | 72 | 0.73 | $40,758 | $21,053 |
| 2015 | 209 | 588 | 71 | 0.77 | $45,451 | $26,722 |
| 2014 | 241 | 344 | 71 | 0.77 | $52,004 | $32,373 |
| 2013 | 279 | 676 | 71 | 0.72 | $52,045 | $33,708 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Short return visit (20+ min) | 15 | $1,109 | $74 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 18 | $984 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 20 | $938 | $47 |
2022: 3 services
| Short return visit (20+ min) | 24 | $2,130 | $76 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 23 | $1,225 | $53 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 22 | $1,021 | $46 |
2021: 3 services
| Short return visit (20+ min) | 24 | $1,995 | $71 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 21 | $1,133 | $54 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 22 | $1,036 | $47 |
2020: 3 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 24 | $1,283 | $53 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 23 | $1,088 | $47 |
| Short return visit (20+ min) | 12 | $876 | $63 |
2019: 3 services
| Short return visit (20+ min) | 33 | $2,350 | $62 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 22 | $1,166 | $53 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 21 | $964 | $46 |
2018: 3 services
| Short return visit (20+ min) | 18 | $1,657 | $64 |
| Return visit (30+ min) | 19 | $1,454 | $77 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 11 | $557 | $51 |
2017: 3 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 32 | $1,651 | $52 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 35 | $1,492 | $43 |
| Short return visit (20+ min) | 16 | $1,116 | $51 |
2016: 5 services
| Long return visit (40+ min) | 94 | $9,494 | $101 |
| Short return visit (20+ min) | 35 | $2,422 | $55 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 13 | $1,530 | $118 |
| Return visit (30+ min) | 12 | $972 | $75 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 17 | $761 | $45 |
2015: 5 services
| Long return visit (40+ min) | 131 | $13,092 | $100 |
| Short return visit (20+ min) | 55 | $4,557 | $61 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 15 | $1,902 | $112 |
| Return visit (30+ min) | 19 | $1,671 | $88 |
| Complete ultrasound scan of pelvis | 11 | $1,287 | $107 |
2014: 7 services
| Long return visit (40+ min) | 140 | $14,438 | $103 |
| Short return visit (20+ min) | 60 | $5,167 | $59 |
| New patient visit (45+ min) | 18 | $2,353 | $131 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 15 | $1,738 | $116 |
| New patient visit (30+ min) | 19 | $1,538 | $81 |
| Complete ultrasound scan of pelvis | 12 | $1,249 | $104 |
| Return visit (30+ min) | 11 | $1,012 | $84 |
2013: 3 services
| Long return visit (40+ min) | 162 | $17,817 | $110 |
| Short return visit (20+ min) | 89 | $6,521 | $55 |
| New patient visit (45+ min) | 16 | $1,914 | $120 |
Drugs they prescribed that Part D paid
$10,319
Pharmacies billed $10,319 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
168 generic and fewer than 11 brand-name prescriptions · $10,319 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 22 | $934 | $42 |
| Levothyroxine | 13 | $122 | $9 |
| Zolpidem | 13 | $42 | $3 |
Year by year
| 2024 | 195 | 33 | None | None | $10,319 |
| 2023 | 165 | 24 | None | None | $11,997 |
| 2022 | 161 | 19 | None | None | $10,903 |
| 2021 | 170 | 28 | None | None | $8,910 |
| 2020 | 200 | 29 | None | 9% | $8,541 |
| 2019 | 146 | 29 | 0% (0) | 8% | $6,627 |
| 2018 | 160 | 24 | 0% (0) | 9% | $6,474 |
| 2017 | 143 | 28 | None | 15% | $7,680 |
| 2016 | 161 | 31 | None | 19% | $8,659 |
| 2015 | 208 | 36 | None | 34% | $11,812 |
| 2014 | 157 | 34 | 0% (0) | 29% | $8,634 |
| 2013 | 150 | 32 | 0% (0) | 52% | $10,512 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Estradiol | 19 | $991 | $52 |
| Levothyroxine | 12 | $197 | $16 |
| Zolpidem | 13 | $36 | $3 |
2022: 4 drugs
| Imvexxy | 15 | $3,519 | $235 |
| Estradiol | 16 | $429 | $27 |
| Levothyroxine | 14 | $268 | $19 |
| Zolpidem | 14 | $38 | $3 |
2021: 3 drugs
| Estradiol | 19 | $1,651 | $87 |
| Levothyroxine | 16 | $288 | $18 |
| Zolpidem | 12 | $37 | $3 |
2020: 5 drugs
| Estradiol | 11 | $596 | $54 |
| Levothyroxine | 13 | $455 | $35 |
| Medroxyprogesterone Acetate | 11 | $64 | $6 |
| Oxybutynin Chloride | 11 | $45 | $4 |
| Zolpidem | 11 | $37 | $3 |
2019: 2 drugs
| Estradiol | 17 | $644 | $38 |
| Medroxyprogesterone Acetate | 18 | $73 | $4 |
2018: 4 drugs
| Estradiol | 44 | $1,247 | $28 |
| Zolpidem Tartrate Er | 11 | $1,117 | $102 |
| Medroxyprogesterone Acetate | 31 | $175 | $6 |
| Zolpidem | 11 | $61 | $6 |
2017: 4 drugs
| Estradiol | 35 | $1,479 | $42 |
| Zolpidem Tartrate Er | 11 | $454 | $41 |
| Medroxyprogesterone Acetate | 25 | $135 | $5 |
| Zolpidem | 12 | $66 | $6 |
2016: 3 drugs
| Estradiol | 47 | $1,127 | $24 |
| Medroxyprogesterone Acetate | 30 | $193 | $6 |
| Zolpidem | 12 | $105 | $9 |
2015: 6 drugs
| Vagifem | 11 | $3,384 | $308 |
| Estradiol | 53 | $1,300 | $25 |
| Progesterone | 21 | $1,203 | $57 |
| Triazolam | 12 | $588 | $49 |
| Medroxyprogesterone Acetate | 36 | $182 | $5 |
| Zolpidem | 11 | $32 | $3 |
2014: 4 drugs
| Vagifem | 12 | $2,334 | $194 |
| Estradiol | 34 | $311 | $9 |
| Medroxyprogesterone Acetate | 35 | $183 | $5 |
| Zolpidem | 14 | $59 | $4 |
2013: 6 drugs
| Vagifem | 14 | $2,301 | $164 |
| Premarin | 12 | $1,844 | $154 |
| Vivelle-Dot | 12 | $887 | $74 |
| Estradiol | 22 | $176 | $8 |
| Medroxyprogesterone Acetate | 15 | $154 | $10 |
| Zolpidem | 22 | $112 | $5 |
Money from drug and device companies
$20 in 2024
A payment is not proof that care is biased.
| Becton Dickinson and | None | $20 | 1 payment
|
See the published payment
| Becton Dickinson and | Meals · 2024-09-25 | None | $20 |
Professional record
- NPI
- 1205885662
- Licence
- CA G64767, CA G647670California G64767: Current · expires 2028-01-31
- Trained
- Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University, 1985
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VX0000X (207VX0000X); Federal specialty code 174400000X (174400000X)
- Mailing address
- 2900 Whipple Ave, #135, Redwood City, CA, 94062
- NPI first listed
- 2006-05-10
- NPI last updated
- 2016-07-18
This is when the NPI record was last certified, not a medical board exam.